Navigation Links
Ventas Enters Agreement to Sell Common Stock
Date:1/29/2008

Gross Proceeds Expected to Be Approximately $168.6 Million

LOUISVILLE, Ky., Jan. 29 /PRNewswire-FirstCall/ -- Ventas, Inc. (NYSE: VTR) ("Ventas" or the "Company") announced today that it has agreed to sell 3,900,000 shares of its common stock to UBS Investment Bank, as sole underwriter, in an underwritten public offering. The Company has also granted UBS Investment Bank a 30-day option to purchase up to an additional 585,000 shares of common stock to cover overallotments, if any. Gross proceeds from the offering (before deducting the underwriting discount and expenses) are expected to be approximately $168.6 million (or $193.9 million if the underwriter's overallotment option is exercised in full). The Company will use the net proceeds to repay indebtedness outstanding under its revolving credit facility and for other general corporate purposes, including acquisitions. Completion of the offering is subject to customary closing conditions.

The shares of common stock are being offered under the Company's existing shelf registration statement, which became automatically effective upon filing with the Securities and Exchange Commission. A prospectus supplement and accompanying prospectus describing the terms of the offering will be filed with the Securities and Exchange Commission. When available, copies of the prospectus supplement and the accompanying prospectus may be obtained from: UBS Investment Bank, 299 Park Avenue, New York, New York 10171, Attention: Prospectus Department, or by phone at 888-827-7275.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sales of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

Ventas, Inc. is a leading healthcare real estate investment trust. Its diverse portfolio of properties located in 43
'/>"/>

SOURCE Ventas, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ventas Grants Stock Awards to Promote Long-Term Retention and Reward Performance
2. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
3. Ventas Appoints Brush SVP - Senior Housing Development and Operations
4. Ventas Announces 2007 Third Quarter Earnings Release Date and Conference Call
5. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
6. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
7. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
8. Excessive overtriage in US trauma centers overwhelming system resources, delaying patient care
9. Labopharm enters into licensing and distribution agreement for once-daily tramadol in Australia with iNova
10. New Company Enters Companion Animal Veterinary Medicine Channel
11. Millennium Enters Into $600,000 Product Development Agreement to Fund Product Development for the $20,000,000 Purchase Agreement with Provider Services, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...re-USNewswire/--Dr.NelsonEscobar,aphysicianwiththe...eJamesBradyAward.TheawardwaspresentedtohimbytheBra...lconferenceonOctober30,2009. ,, AccordingtotheB...onofhisexpertiseinaddressingthecomplexneedsofperso...ceptionalcareofhispatientsandtheirfamiliesastheyre...
(Date:11/24/2009)...ard off peripheral artery disease, researchers sa...-- Among people aged 75 and older, the herbal supp...s, stroke or death, a new study finds. , There ...ght help prevent the leg-circulation problem known...o contains nutrients called flavonoids, which are ...
(Date:11/24/2009)...nd that hormones produced during pregnancy induce ...ast cancer. This protein, alpha-fetoprotein (AFP),...he treatment and prevention of breast cancer, acco...Research , a journal of the American Association f...uch as estrogen, all induce AFP, which directly in...
(Date:11/24/2009)...Newswire/--Thereisanewgameintownwhenitcomestodeali...agmaticandrealisticstrategieswheretraditionalappro...ovementisagroupcalledHAMS--HarmReduction,AlcoholAb...,lay-ledsupportandinformationalgroupforpeoplewhodr...seandAlcoholismtellsusthatonly7%ofpeoplewithanalco...
(Date:11/24/2009)...re/--Thankstoaninnovativeprogramrecentlydevelopedb...BlueCrossandBlueShieldinMaine,someAnthemmembersinB...outleavinghome. ,, Aspartofthepilot,Anthemmembe...dcommunicateviaemailwiththeirprovideraboutnon-emer...kingontestresults,orrequestingprescriptionrefills....
Breaking Medicine News(10 mins):Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3Health News:Protein from pregnancy hormone may prevent breast cancer 2Health News:Harm Reduction for Alcohol: An Idea Whose Time Has Arrived 2Health News:The Doctor Will See You Now. . .Online 2
... drugs heighten suicide risk, and they recommend m...July 10 (HealthDay News) -- Anti-seizure drugs ca... but not enough to warrant the government,s strong... findings on 11 antiepileptic drugs studied by the...
...with a tip the size of a needle, Stanford research... muscles in live humans, with minimum discomfort t...lcome. , This microendoscopy technique for viewin...n which a portion of the muscle is removed for exa...
...seizure drugs that showed double the risk , ...izure drugs can cause increased suicidal tendencie...ded Thursday. , The 20-member panel of experts vot...late January, the FDA announced an agency review ...
...cago and Los Angeles Life Time Fitness ...uly 10 MGD 64 today announced it will,sponsor thr...s Race to the,Toyota Cup events: the July 12 Life ...exclusive beer sponsor of the events, MGD 64 will ...
... restaurant during the breakfast rush the clang o...ces was the crucial test of new hearing aid techn...ngton University School of Medicine in St. Louis. ...devices didn,t need to fly from St. Louis to Chica...
...rther Positions the Company as a Weight Loss ...if., July 10 Jenny Craig, Inc. is pleased,to anno... for the worldwide,rights to use the Volumetrics(R... author of the New York Times,bestselling books Th...
Other Medicine News:Health News:FDA Advisers Don't Back Epilepsy Drug Warnings 2Health News:Stanford Bio-X researchers use needle-thin probe to get first look at working muscle fiber 2Health News:Epilepsy Drugs Can Cause Suicidal Tendencies, FDA Panel Finds 2Health News:Epilepsy Drugs Can Cause Suicidal Tendencies, FDA Panel Finds 3Health News:MGD 64 to Sponsor National Triathlons 2Health News:MGD 64 to Sponsor National Triathlons 3Health News:New hearing aid technology passes the restaurant noise test 2Health News:New hearing aid technology passes the restaurant noise test 3Health News:Jenny Craig Establishes License Agreement for Volumetrics(R) 2Health News:Jenny Craig Establishes License Agreement for Volumetrics(R) 3
(Date:11/24/2009)..., CARLSBAD,Calif.,Nov.24/PRNewswire-FirstCall/--Is...ntisensetherapeutics,todayannouncedthatmanagementw...alHealthCareConferenceonTuesday,December1,2009,at1...owebcastofthepresentationwillbeavailableonthe"Inve...isispharm.com .Areplayofthepresentationwillbeavail...
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire-FirstCall/--OptimerPh...entatthe21stAnnualPiperJaffrayHealthCareConference...:00p.m.EasternTime. ,, (Logo: http://www.newsco...iveaudiowebcastofthispresentationwillbeaccessibleo...merpharma.com .Replaysofthispresentationwillbeava...
(Date:11/24/2009)..., NEWYORK,Nov.24/PRNewswire-FirstCall/--KeryxBioph...tRonBentsur,theCompany,sChiefExecutiveOfficer,issc...areConferencebeingheldinNewYorkCity. ,, Mr.Bent...mber2ndat10:30AMETandwillbeaccessiblefromtheInvest...vestors.keryx.com .Anarchivedversionofthewebcastwi...
Breaking Medicine Technology:Keryx Biopharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2NovaMin Technology Inc Welcomes New Board Member 14112 1NovaMin Technology Inc Welcomes New Board Member 14112 2Teamsters Oppose Baucus Plan to Tax Health Insurance Companies 57442 1Teamsters Oppose Baucus Plan to Tax Health Insurance Companies 57442 2Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 1Baucus Bill Imposes Additional Tax Burdens on Nonprofit Hospitals 57437 2
...n Cohort 3 Demonstrated Improvement in T-Cell Resp...otential of HspE7, SAN DIEGO, May 12 Nventa Biop...ced positive immunological data from the,third coh...ead product,candidate, HspE7, in patients with cer...or to cervical cancer. HPV 16 E7-specific T-cell r...
...icine Studied in Patients Following Bunionectomy,...xperience intense pain for several days following ...urgeries. The investigational pain,medication tape...o had this,surgery, compared to those treated with...in patients reporting fewer gastrointestinal side ...
Other Medicine Technology:Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 5
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: